about
Unique pattern of component gene disruption in the NRF2 inhibitor KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex in serous ovarian cancerArsenic exposure and the induction of human cancersHuman cancer long non-coding RNA transcriptomes.SIGMA2: a system for the integrative genomic multi-dimensional analysis of cancer genomes, epigenomes, and transcriptomes.An integrative multi-dimensional genetic and epigenetic strategy to identify aberrant genes and pathways in cancer.Frequent concerted genetic mechanisms disrupt multiple components of the NRF2 inhibitor KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex in thyroid cancer.DNA methylation is globally disrupted and associated with expression changes in chronic obstructive pulmonary disease small airwaysLung adenocarcinoma of never smokers and smokers harbor differential regions of genetic alteration and exhibit different levels of genomic instability.Smoking status impacts microRNA mediated prognosis and lung adenocarcinoma biologyGenomic deregulation of the E2F/Rb pathway leads to activation of the oncogene EZH2 in small cell lung cancer.Comprehensive analysis of HPV16 integration in OSCC reveals no significant impact of physical status on viral oncogene and virally disrupted human gene expression.Unique somatic and malignant expression patterns implicate PIWI-interacting RNAs in cancer-type specific biologyEYA4 is inactivated biallelically at a high frequency in sporadic lung cancer and is associated with familial lung cancer risk.Microtubule affinity-regulating kinase 2 is associated with DNA damage response and cisplatin resistance in non-small cell lung cancer.Epigenetics of cancer progression.Methylated DNA immunoprecipitation.YEATS4 is a novel oncogene amplified in non-small cell lung cancer that regulates the p53 pathway.Copy number variations in the human genome and strategies for analysis.The detection and implication of genome instability in cancerMultiple Components of the VHL Tumor Suppressor Complex Are Frequently Affected by DNA Copy Number Loss in Pheochromocytoma.Disruption of KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex components by multiple genetic mechanisms: Association with poor prognosis in head and neck cancer.Whole-genome sequencing analysis identifies a distinctive mutational spectrum in an arsenic-related lung tumor.Methylation analysis by DNA immunoprecipitation (MeDIP).Array comparative genomic hybridization reveals similarities between nodular lymphocyte predominant Hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma.Lung tumors and non-malignant airways from patients with chronic lung inflammatory disease bear distinct genetic and epigenetic disruptions corresponding to metabolic processes involved in senescence and methylationComparative Cancer EpigenomicsEmerging Arsenic Threat in CanadaElevated Expression of BIRC6 Protein in Non–Small-Cell Lung Cancers is Associated with Cancer Recurrence and ChemoresistanceArsenic and Lung Cancer in Never-Smokers: Lessons from Chile
P50
Q28391727-96061521-0858-48BC-B0DF-D945E0F63152Q28394700-9379C625-F6FF-4642-8714-2A2EB4CE6A56Q31032840-4A00D169-025E-4FF5-BA65-B1DB2A9CFA5DQ33374429-CE86B554-934A-4BDC-9107-C1BF179A3769Q33579640-8984EF43-641C-4C7D-AE42-9450D9075A25Q33591232-4388D1FA-C75D-4EAF-819A-2B4724CEC7F6Q33799715-612CA0A5-A84C-40A5-9765-45D9A9920577Q34193618-ECBB74C1-4EB9-485D-88EF-EF10618852A7Q34436424-A72B0E72-17F3-45CE-9645-43D61855ADD9Q34964303-FC99BD27-3757-443A-BC8B-BDD8EF92DA2AQ35106230-983E26E3-DB1C-42D5-903E-E86EEC678871Q35650948-257FE2A7-77E3-4A4A-8E75-8732150F51E4Q35924241-56141B4D-1055-455E-9047-1E28C841CADCQ35957598-38209D87-9E6A-4F5C-A63D-3E303BFC6116Q37120846-021261FF-6405-4FA3-BD66-B6A31708A2C2Q37390394-9E41A900-DBA8-4DA1-9034-7ED3B935412EQ37649231-CB067BC3-C520-4695-B22D-68033B9DDE77Q37711216-12E2505E-0D1D-4306-83D9-D53E627DBCC3Q38103187-DD14C424-FE2A-467C-91CC-A04378708015Q42101114-7C3A5468-F9B1-4FD4-A5D0-5337EFD85F58Q43585117-3D6CDB50-4945-4947-B143-0AC114C22BADQ46508598-5100C1A9-3D17-4F59-9659-78783EBB7E14Q51933476-EEA19C9C-0CEE-46C9-A2FD-35383A964660Q53628430-70EFF1F6-F6DF-4493-843F-2595FBF3EFA4Q59322904-CFB6798F-F9C7-443F-B40B-E0799FFF7894Q60738571-3AACDE6D-ED2A-4BC1-A88B-2C805D20E5D8Q61312528-BD2946CE-8644-4AEE-86AA-0FFB59DC4C66Q61312532-1F472CEF-9C24-476D-9CC1-949BD41889C3Q61312536-32A60466-18E5-4A7C-A701-DB654E34554E
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Emily A Vucic
@ast
Emily A Vucic
@en
Emily A Vucic
@es
Emily A Vucic
@nl
Emily A Vucic
@sl
type
label
Emily A Vucic
@ast
Emily A Vucic
@en
Emily A Vucic
@es
Emily A Vucic
@nl
Emily A Vucic
@sl
prefLabel
Emily A Vucic
@ast
Emily A Vucic
@en
Emily A Vucic
@es
Emily A Vucic
@nl
Emily A Vucic
@sl
P106
P21
P31
P496
0000-0002-2728-8708